卒中:回眸2023 Highlights in Stroke in 2023

在全球脑血管病医疗工作者的共同努力下,近年来脑血管病的诊疗取得了长足的进步。众多高质量的临床研究涵盖了脑血管病多个领域和热点,例如:缺血性卒中急性期取栓/溶栓,针对心房颤动的干预,血压管理等其他卒中急性期干预措施,为脑血管病的临床诊疗提供了扎实可靠的循证医学证据,并促进了脑血管病疾病负担的降低。本文对2023年脑血管病领域重要的临床研究进展进行回顾,帮助读者更好地了解这些临床研究的精华,并期待未来涌现出更多、更好的脑血管病临床研究。 Abstract: Cerebrovascular clinicians from different countries all over the world...

Full description

Bibliographic Details
Main Author: WANG Yongjun1,2,3,4,5,6, XIONG Yunyun1,2,3,7, LI Guangshuo1, CAO Zhixin1, WANG Wenjie1, YAN Ran1, WANG Liyuan1, LU Zhengzhao1, HAO Manjun1
Format: Article
Language:zho
Published: Editorial Department of Chinese Journal of Stroke 2024-01-01
Series:Zhongguo cuzhong zazhi
Subjects:
Online Access:http://www.chinastroke.org.cn/CN/article/openArticlePDF.jsp?id=3951
_version_ 1797347970445737984
author WANG Yongjun1,2,3,4,5,6, XIONG Yunyun1,2,3,7, LI Guangshuo1, CAO Zhixin1, WANG Wenjie1, YAN Ran1, WANG Liyuan1, LU Zhengzhao1, HAO Manjun1
author_facet WANG Yongjun1,2,3,4,5,6, XIONG Yunyun1,2,3,7, LI Guangshuo1, CAO Zhixin1, WANG Wenjie1, YAN Ran1, WANG Liyuan1, LU Zhengzhao1, HAO Manjun1
author_sort WANG Yongjun1,2,3,4,5,6, XIONG Yunyun1,2,3,7, LI Guangshuo1, CAO Zhixin1, WANG Wenjie1, YAN Ran1, WANG Liyuan1, LU Zhengzhao1, HAO Manjun1
collection DOAJ
description 在全球脑血管病医疗工作者的共同努力下,近年来脑血管病的诊疗取得了长足的进步。众多高质量的临床研究涵盖了脑血管病多个领域和热点,例如:缺血性卒中急性期取栓/溶栓,针对心房颤动的干预,血压管理等其他卒中急性期干预措施,为脑血管病的临床诊疗提供了扎实可靠的循证医学证据,并促进了脑血管病疾病负担的降低。本文对2023年脑血管病领域重要的临床研究进展进行回顾,帮助读者更好地了解这些临床研究的精华,并期待未来涌现出更多、更好的脑血管病临床研究。 Abstract: Cerebrovascular clinicians from different countries all over the world made great progress in the diagnosis and treatment of cerebral vascular diseases in recent years. Numerous high-quality clinical studies cover multiple fields and hotspots of cerebral vascular disease, such as thrombectomy/thrombolysis in the acute phase of ischemic stroke, intervention for atrial fibrillation, blood pressure management and other acute phase intervention measures, providing solid and reliable evidence-based medical evidence for clinical diagnosis and treatment in cerebral vascular disease, and promoting the reduction of cerebral vascular disease burden. This paper reviews the important clinical research progress in the field of cerebral vascular disease in 2023, helping readers better understand the advantages and great significance of these clinical studies, and looking forward to more and better cerebral vascular disease clinical studies in the future.
first_indexed 2024-03-08T11:56:38Z
format Article
id doaj.art-a701687c3e3c4e549c0a82a60d424cfa
institution Directory Open Access Journal
issn 1673-5765
language zho
last_indexed 2024-03-08T11:56:38Z
publishDate 2024-01-01
publisher Editorial Department of Chinese Journal of Stroke
record_format Article
series Zhongguo cuzhong zazhi
spelling doaj.art-a701687c3e3c4e549c0a82a60d424cfa2024-01-24T01:31:35ZzhoEditorial Department of Chinese Journal of StrokeZhongguo cuzhong zazhi1673-57652024-01-0119112110.3969/j.issn.1673-5765.2024.01.001卒中:回眸2023 Highlights in Stroke in 2023WANG Yongjun1,2,3,4,5,6, XIONG Yunyun1,2,3,7, LI Guangshuo1, CAO Zhixin1, WANG Wenjie1, YAN Ran1, WANG Liyuan1, LU Zhengzhao1, HAO Manjun1 0WANG Yongjun, E-mail: yongjunwang@ncrcnd.org.cn在全球脑血管病医疗工作者的共同努力下,近年来脑血管病的诊疗取得了长足的进步。众多高质量的临床研究涵盖了脑血管病多个领域和热点,例如:缺血性卒中急性期取栓/溶栓,针对心房颤动的干预,血压管理等其他卒中急性期干预措施,为脑血管病的临床诊疗提供了扎实可靠的循证医学证据,并促进了脑血管病疾病负担的降低。本文对2023年脑血管病领域重要的临床研究进展进行回顾,帮助读者更好地了解这些临床研究的精华,并期待未来涌现出更多、更好的脑血管病临床研究。 Abstract: Cerebrovascular clinicians from different countries all over the world made great progress in the diagnosis and treatment of cerebral vascular diseases in recent years. Numerous high-quality clinical studies cover multiple fields and hotspots of cerebral vascular disease, such as thrombectomy/thrombolysis in the acute phase of ischemic stroke, intervention for atrial fibrillation, blood pressure management and other acute phase intervention measures, providing solid and reliable evidence-based medical evidence for clinical diagnosis and treatment in cerebral vascular disease, and promoting the reduction of cerebral vascular disease burden. This paper reviews the important clinical research progress in the field of cerebral vascular disease in 2023, helping readers better understand the advantages and great significance of these clinical studies, and looking forward to more and better cerebral vascular disease clinical studies in the future. http://www.chinastroke.org.cn/CN/article/openArticlePDF.jsp?id=3951卒中脑血管病再灌注血管内治疗静脉溶栓心房颤动二级预防strokecerebralvascular diseasereperfusionendovascular treatmentintravenous thrombolysisatrial fibrillationsecondary prevention
spellingShingle WANG Yongjun1,2,3,4,5,6, XIONG Yunyun1,2,3,7, LI Guangshuo1, CAO Zhixin1, WANG Wenjie1, YAN Ran1, WANG Liyuan1, LU Zhengzhao1, HAO Manjun1
卒中:回眸2023 Highlights in Stroke in 2023
Zhongguo cuzhong zazhi
卒中
脑血管病
再灌注
血管内治疗
静脉溶栓
心房颤动
二级预防
stroke
cerebralvascular disease
reperfusion
endovascular treatment
intravenous thrombolysis
atrial fibrillation
secondary prevention
title 卒中:回眸2023 Highlights in Stroke in 2023
title_full 卒中:回眸2023 Highlights in Stroke in 2023
title_fullStr 卒中:回眸2023 Highlights in Stroke in 2023
title_full_unstemmed 卒中:回眸2023 Highlights in Stroke in 2023
title_short 卒中:回眸2023 Highlights in Stroke in 2023
title_sort 卒中 回眸2023 highlights in stroke in 2023
topic 卒中
脑血管病
再灌注
血管内治疗
静脉溶栓
心房颤动
二级预防
stroke
cerebralvascular disease
reperfusion
endovascular treatment
intravenous thrombolysis
atrial fibrillation
secondary prevention
url http://www.chinastroke.org.cn/CN/article/openArticlePDF.jsp?id=3951
work_keys_str_mv AT wangyongjun123456xiongyunyun1237liguangshuo1caozhixin1wangwenjie1yanran1wangliyuan1luzhengzhao1haomanjun1 zúzhōnghuímóu2023highlightsinstrokein2023